TSS
GTHX

Two Sigma Securities’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Two Sigma Securities’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,976
Closed -$42.6K – 3800
2023
Q4 		$42.6K Buy
+13,976
New +$26.3K ﹤0.01% 2629
2023
Q3 		– Sell
-12,587
Closed -$31.3K – 3598
2023
Q2 		$31.3K Buy
+12,587
New +$34.4K ﹤0.01% 2454
2018
Q4 		– Sell
-5,139
Closed -$269K – 2950
2018
Q3 		$269K Buy
+5,139
New +$280K ﹤0.01% 1845

Other funds holding GTHX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Securities's GTHX Position: Q1 2024 in Review

Two Sigma Securities sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2024, closing a stake of 13,976 shares — an estimated $42.6K sold.

Two Sigma Securities first reported a position in GTHX in Q3 2018 and held it in 3 quarters. The position peaked at $269K in Q3 2018. 86 funds tracked by Wall St. Rank hold GTHX as of Q1 2024.

  • Two Sigma Securities reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 13,976 G1 Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $42.6K.
  • Two Sigma Securities first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2018 and held it in 3 quarters.
  • Two Sigma Securities's G1 Therapeutics, Inc. Common Stock position peaked at $269K in Q3 2018.
  • 86 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.